ATR and cancer: These results suggest that the effects of ATR inhibition synergize with those of DNA-damaging chemotherapeutic agents, such as cisplatin, to kill cancer cells, most likely via a cisplatin-dependent increase in replication stress rather than via elevated cisplatin-induced DNA damage in the absence of ATR activity.